Human Recombinant Interferon-α2a Polybutylcyanoacrylate Sustained Release Lyophilized Nanospheres for Liver-Targeting

Journal of Sichuan University (Medical Science)

Volumn 35, Issue 1, 2004, Pages 1-4

  Lu, Bin ^a   Feng, Jian Fang ^a   Yang, Xiu Cen ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Human recombinant interferon 2a; Liver targeted and sustained release delivery system; Polybutylcyanoacrylate nanospheres

Indexed keywords

CYANOACRYLATE DERIVATIVE; NANOPARTICLE; RECOMBINANT ALPHA2A INTERFERON; RECOMBINANT ALPHA2A INTERFERON POLYBUTYL CYANOACRYLATE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONCENTRATION (PARAMETERS); DRUG ACTIVITY; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG MANUFACTURE; DRUG SCREENING; DRUG STORAGE; DRUG TISSUE LEVEL; EMULSION; FREEZE DRYING; IN VIVO STUDY; LIVER; MOUSE; NONHUMAN; PARTICLE SIZE; POLYMERIZATION; SAMPLE; SUSTAINED RELEASE PREPARATION; TARGET ORGAN; TIME;

EID: 1642569326     PISSN: 1672173X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Pean JM, Venier-Julienne MC, Filmon R, et al. Optimization of HAS and NGF encapsulation yields in PLGA microparticles. Int J Pharm, 1998; 166:105.
2. Eyles JE, Alpar HO, Conway BR, et al. Oral delivery and fate of poly (lactic acid) microsphere-encapsulated interferon in rats. J Pharm Pharmacol, 1997; 49(7):669.
3. Tabata Y, Ikada Y. Synthesis of gelatin microspheres containing interferon. Pharm Res, 1989; 6(5):422.
4. 3H-rIFNα2 and nIFNα administrated intradermally in rabbits. Int J Pharm, 1986; 32:103.
5. Maitani Y, Uchida N, Taniguchi S, et al. Inactivation process or IFNβ in the preparation stage and in rabbit nasal absorption of mixed and freezed-dried powder dosage form. Int J Pharm, 1990; 14:139.
6. Shoham J, Cohen M, Wallach D. An immunoenzyme quantitative assay for the antiviral effect of IFNs. J Immunology Methods, 1984; 72(1):279.
7. Fujioka K, Takada Y, Sato S. et al. Novel delivery system for proteins using collagen as a carrier material: the minipellet. J Controlled Release. 1996; 33(1-3):307.
8. Matsukawa Y, Nishinarita S, Horie T, et al. Serum concentration of interferon-alpha: a comparison between once-a-day and twice-a-day administration. Int J Clin Pharmacol Res, 2000; 20(1-2):17.